Romosozumab FRAME Study: A Post Hoc Analysis of the Role of Regional Background Fracture Risk on Nonvertebral Fracture Outcome

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
Felicia CosmanAndreas Grauer

Abstract

In the pivotal Fracture Study in Postmenopausal Women with Osteoporosis (FRAME; NCT01575834), 1 year of the bone-forming agent romosozumab significantly reduced new vertebral and clinical fracture risk versus placebo. Nonvertebral fracture risk was not significantly reduced in the overall population, influenced by a low placebo-group fracture rate, observed particularly in the highest-enrolling region of Latin America. In year 1 of FRAME, postmenopausal women with a T-score of -2.5 to -3.5 at the total hip or femoral neck were randomized to subcutaneous romosozumab 210 mg or placebo once monthly for 12 months. Of 7180 randomized women, 43% were from Latin America, largely Colombia and Brazil. Prespecified analyses assessed fracture risk reductions by geographic regions. A significant treatment-by-geographic region interaction for the clinical (p = 0.029) and nonvertebral fracture (p = 0.042) endpoints led to further characterization of the Latin American population and comparison with the remaining study population, grouped post hoc as rest-of-world. Nonvertebral fracture efficacy in the overall population was also assessed by baseline fracture risk using the Fracture Risk Assessment Tool (FRAX). Romosozumab significantly and c...Continue Reading

References

Sep 1, 1993·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·H K GenantM C Nevitt
Apr 18, 1998·The Journal of Bone and Joint Surgery. British Volume·B R SingerJ Christie
Oct 31, 2001·Journal of Bone and Mineral Metabolism·H OrimoH Kishimoto
Jan 11, 2003·Arthritis and Rheumatism·J Timothy HarringtonDavid A Shewmon
Nov 18, 2003·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·Martien J M PannemanRon M C Herings
May 4, 2007·The New England Journal of Medicine·Dennis M BlackUNKNOWN HORIZON Pivotal Fracture Trial
Aug 5, 2008·Annals of the Rheumatic Diseases·T A C M van GeelG-J Dinant
Aug 13, 2009·The New England Journal of Medicine·Steven R CummingsUNKNOWN FREEDOM Trial
Jan 12, 2010·Menopause : the Journal of the North American Menopause Society
Jul 2, 2010·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Desmond PadhiEdward Posvar
Mar 16, 2012·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J A KanisUNKNOWN IOF Working Group on Epidemiology and Quality of Life
Mar 21, 2012·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Eugene V McCloskeyJohn A Kanis
Mar 9, 2013·Calcified Tissue International·J J Jaller-RaadJ A Kanis
Jan 3, 2014·The New England Journal of Medicine·Michael R McClungHenry G Bone
Aug 13, 2014·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·A WilkP Mavros
Sep 4, 2014·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·F CosmanR Lindsay
Aug 26, 2015·Archives of Osteoporosis·C A F ZerbiniJ A Kanis
Aug 18, 2016·JAMA : the Journal of the American Medical Association·Paul D MillerUNKNOWN ACTIVE Study Investigators
Nov 1, 2016·The New England Journal of Medicine·Felicia CosmanAndreas Grauer
Sep 24, 2016·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Pauline M CamachoNelson B Watts
Dec 14, 2016·The New England Journal of Medicine·Salim Yusuf, Janet Wittes
Sep 12, 2017·The New England Journal of Medicine·Kenneth G SaagAndreas Grauer

❮ Previous
Next ❯

Citations

Jan 19, 2019·Journal of Internal Medicine·Mattias Lorentzon
Sep 16, 2018·British Journal of Clinical Pharmacology·Gaia Tabacco, John P Bilezikian
May 16, 2019·Current Opinion in Rheumatology·Felicia Cosman
Aug 6, 2020·Immunotherapy·Alexandra O KobzaJonathan D Adachi
Mar 12, 2020·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Felicia Cosman
Sep 17, 2020·Journal of Developmental Biology·Daniel HalloranAnja Nohe
Feb 26, 2019·Drugs·Anthony Markham
Dec 21, 2019·Wiener medizinische Wochenschrift·Katharina Kerschan-Schindl
Aug 31, 2020·The Annals of Pharmacotherapy·Kimberly Lovin Nealy, Kira B Harris
May 13, 2020·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·Y E KwonY J Kwon
Oct 22, 2019·Therapeutic Advances in Musculoskeletal Disease·Salvatore MinisolaJessica Pepe
Sep 11, 2020·Drugs & Aging·Julia Paik, Lesley J Scott
Dec 7, 2018·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·E Michael LewieckiAndreas Grauer
Oct 30, 2020·Journal of Clinical Medicine·Stéphanie FabreMartine Cohen-Solal
Jan 30, 2021·Wiener medizinische Wochenschrift·Roland KocijanJochen Zwerina
Nov 6, 2020·Nature Reviews. Endocrinology·Eben G Estell, Clifford J Rosen
Jan 21, 2021·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Felicia Cosman
Feb 5, 2021·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·E V McCloskeyJ A Kanis
Jan 8, 2021·Current Osteoporosis Reports·Cy Fixen, Jennifer Tunoa
Nov 19, 2020·Journal of Bone and Mineral Metabolism·Sakae Tanaka, Toshio Matsumoto
Feb 27, 2021·Current Osteoporosis Reports·Felicia Cosman, David W Dempster
Mar 7, 2021·Journal of Clinical Medicine·Martina RaunerElizabeth M Winter
Aug 14, 2021·Bone Reports·Iconaru LauraBergmann Pierre
Aug 4, 2021·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Sara KhalidDaniel Prieto-Alhambra

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Clinical Endocrinology and Metabolism
Richard EastellHORIZON Pivotal Fracture Trial
Climacteric : the Journal of the International Menopause Society
S PalaciosS Adami
The New England Journal of Medicine
Felicia CosmanAndreas Grauer
© 2022 Meta ULC. All rights reserved